Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Published 20/11/2023, 19:35
© Reuters.  Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga - by Lisa Levin, Benzinga Editor.

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales.

ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.

ReNew Energy raised its FY24 adjusted EBITDA guidance to INR 62 billion - INR 66 billion.

ReNew Energy Global gained 13.6% to $6.74 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Bruush Oral Care Inc. (NASDAQ: BRSH) shares jumped 147.2% to $0.4179. Brüush received Nasdaq notification regarding minimum bid requirements.
  • Cuentas Inc. (NASDAQ: CUEN) shares gained 59% to $1.5098 after reporting a narrower quarterly loss.
  • Altamira Therapeutics Ltd. (NASDAQ: CYTO) jumped 52% to $0.4280. Altamira Therapeutics recently entered into a binding agreement for the sale of a 51% stake in its subsidiary Altamira Medica AG.
  • Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 41.4% to $1.4000. Cardio Diagnostics Holdings announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the American Heart Association.
  • YPF Sociedad Anónima (NYSE: YPF) shares climbed 40.8% to $15.11. Javier Milei‘s victory in Argentina’s presidential election sparked a rally in Argentine ADRs trading on major U.S. stock exchanges.
  • GD Culture Group Limited (NASDAQ: GDC) rose 26.8% to $4.3074. GD Culture Group unveiled its transformative and photorealistic AI-driven digital human technology on TikTok.
  • Blue Star Foods Corp. (NASDAQ: BSFC) shares gained 26.8% to $0.1752 after jumping 18% on Friday. Blue Star Foods recently signed a 2-year bid award purchase agreement with Sysco Corporation.
  • MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) gained 25.3% to $4.2729. MIRA Pharmaceuticals announced exclusive licensing agreement for oral ketamine analog, Ketamir-2.
  • Grupo Financiero Galicia S.A. (NASDAQ: GGAL) rose 25% to $15.63 after gaining 5% on Friday.
  • Transportadora de Gas del Sur S.A. (NYSE: TGS) shares climbed 23.1% to $12.88 after gaining over 4% on Friday.
  • Central Puerto S.A. (NYSE: CEPU) climbed 23.1% to $7.58.
  • Pampa Energía S.A. (NYSE: PAM) gained 23% to $45.60.
  • Transportadora de Gas del Sur S.A. (NYSE: TGS) rose 22.6% to $12.82 after gaining over 4% on Friday.
  • Banco BBVA Argentina S.A. (NYSE: BBAR) gained 22.4% to $5.40.
  • LogicMark, Inc. (NASDAQ: LGMK) shares rose 22.2% to $2.04. LogicMark recently posted GAAP loss of $1.10 per share for the third quarter.
  • IRSA Inversiones y Representaciones Sociedad Anónima (NYSE: IRS) gained 20.3% to $7.79.
  • Telecom Argentina S.A. (NYSE: TEO) climbed 19.4% to $6.40 after gaining around 4% on Friday.
  • Banco Macro S.A. (NYSE: BMA) gained 17.1% to $23.71.
  • HireRight Holdings Corporation (NYSE: HRT) jumped 17.4% to $11.81 after gaining 5% on Friday.
  • Yoshiharu Global Co. (NASDAQ: YOSH) shares climbed 15.7% to $0.4050. The company recently reported an increase in quarterly sales.
  • Gyre Therapeutics, Inc. (NASDAQ: GYRE) gained 15.6% to $17.00.
  • MediciNova, Inc. (NASDAQ: MNOV) rose 15.2% to $2.0508. The company announced new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma presented at the 28th Annual Meeting of the Society for Neuro-Oncology.
  • Kronos Bio, Inc.(NASDAQ: KRON) gained 14.4% to $1.2699. Kronos recently posted downbeat quarterly results.
  • Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) gained 14.4% to $6.80.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) rose 13.6% to $5.74. Goldman Sachs initiated coverage on Iovance Biotherapeutics with a Buy rating and announced a price target of $12.
  • Anavex Life Sciences Corp. (NASDAQ: AVXL) jumped 11.8% to $7.01. The clinical-stage biopharmaceutical company announced that it initiated a regulatory submission with the European Medicines Agency (EMA).
  • Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 11.7% to $31.42. Intellia Therapeutics recently announced it received European Union orphan drug designation for NTLA-2002.
  • XPeng Inc. (NYSE: XPEV) gained 9% to $18.30.
  • Motus GI Holdings, Inc. (NASDAQ: MOTS) gained 7.6% to $3.98 after declining around 5% on Friday. Motus GI recently announced the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance.
  • NIO Inc. (NYSE: NIO) fell 6.2% to $7.85. Nio announced on Sunday that it has activated its 2,100th power swap station.
  • Coinbase Global, Inc. (NASDAQ: COIN) gained 4.2% to $103.12.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • NanoString Technologies, Inc. (NASDAQ: NSTG) shares fell 46% to $0.69. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.
  • PaxMedica, Inc. (NASDAQ: PXMD) fell 40.6% to $1.04 after the company announced pricing of $7 million public offering of 5,384,615 shares and accompanying warrants at a price of $1.30 per unit.
  • Safe and Green Development Corporation (NASDAQ: SGD) fell 25.5% to $3.14. Safe And Green Development shares jumped 39% on Friday after the company said it does not intend to conduct the offering of the shares of common stock contemplated by the Registration Statement.
  • Alzamend Neuro, Inc. (NASDAQ: ALZN) dipped 25% to $1.2400. Alzamend Neuro received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for major depressive disorder (MDD).
  • Yatsen Holding Limited (NYSE: YSG) fell 24.2% to $0.6559. Yatsen Holding is expected to release its unaudited financial results for the third quarter on Nov. 21, 2023.
  • 2seventy bio, Inc. (NASDAQ: TSVT) declined 16.4% to $1.78. The FDA's Oncologic Drugs Advisory Committee (ODAC) will meet to review data supporting the supplemental Biologics License Application (sBLA) for Abecma (idecabtagene vicleucel) for earlier lines of triple-class exposed relapsed or refractory multiple myeloma (RRMM) based on results from the pivotal Phase 3 KarMMa-3 study.
  • Allurion Technologies Inc. (NYSE: ALUR) fell 12.6% to $3.72.
  • Safe & Green Holdings Corp. (NASDAQ: SGBX) shares fell 12.6% to $0.6821 after gaining around 7% on Friday. Safe & Green Holdings recently posted a narrower-than-expected quarterly loss.
  • Greenland Technologies Holding Corporation (NASDAQ: GTEC) declined 12.5% to $2.87 following weak quarterly results.
  • reAlpha Tech Corp. (NASDAQ: AIRE) declined 10.5% to $8.40. ReAlpha Tech filed a prospectus for the offering of up to 1.67 million common units at a price of $12 per unit.
  • Applied UV, Inc. (NASDAQ: AUVI) shares fell 9.4% to $0.1340 after the company reported third-quarter results.
  • MGO Global, Inc. (NASDAQ: MGOL) shares fell 9.1% to $0.50 after jumping over 10% on Friday. MGO Global recently posted a wider third-quarter loss.
  • Genelux Corporation (NASDAQ: GNLX) declined 8.7% to $10.83.
  • Tharimmune, Inc. (NASDAQ: THAR) shares fell 8.6% to $0.1922. Tharimmune shares climbed around 17% on Friday after the company announced a 1-for-25 reverse stock split.
  • Chegg, Inc. (NYSE: CHGG) fell 8.2% to $9.60. Morgan Stanley downgraded Chegg from Equal-Weight to Underweight and lowered the price target from $10 to $9.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.